From: Synergistic breast cancer therapy with RGD-decorated liposomes co-delivering mir-34a and cisplatin
Samples
IC50 for 24 h
miR34a-Cis
6.20 ± 0.35
miR34a-Cis-Lip
5.41 ± 0.36
miR34a-Cis-Lip-RGD
3.90 ± 0.23